{
 "PrintNo":"A2783","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-01-25T16:07:57.488993Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-01-25","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":590,"Name":"Robin Schimminger","Short":"SCHIMMINGER"}],
 "Title":"Provides for increasing the applicability of brand name and generic prescription drug and other medical services co-payments for medicaid recipients",
 "Summary":"Provides for increasing the applicability of brand name and generic prescription drugs and other medical services, except diagnostic services, co-payments for medicaid recipients.",
 "LawSection":"Social Services Law","LawCode":"Amd ยง367-a, Soc Serv L",
 "ActClause":"AN ACT to amend the social services law, in relation to medicaid co-payments for prescription drugs and other services",
 "PreviousVersions":["A4676-2007","A6678-2009","A2339-2011","A2640-2013","A6363-2015","A2002-2017"]
}